BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3
209 results:

  • 1. CALCRL knockdown suppresses cancer stemness and chemoresistance in acute myeloid leukemia with FLT3-ITD and DNM3TA-R882 double mutations.
    Tang S; Zhu H; Sheng L; Mu Q; Wang Y; Xu K; Zhou M; Xu Z; Wu A; Ouyang G
    Drug Dev Res; 2024 Feb; 85(1):e22137. PubMed ID: 38349260
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Significance of oct3/4 and SOX2 antigens expression by leukemic blast cells in adult acute leukemia.
    Aref S; Khaled O; Menshawy NE; Azmy E; Aref M; Salama O; Khaled N
    J Egypt Natl Canc Inst; 2024 Feb; 36(1):5. PubMed ID: 38342816
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. An In Vitro Model for Acute Myeloid leukemia Relapse Using the SORE6 Reporter.
    Lai J; Shang C; Chen W; Izevbaye I; Chu MP; Sandhu I; Brandwein J; Lai R; Wang P
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203669
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Generation and characterization of iPS cell line (SYSUSHi002-A) from PBMCs of an AML patient with TP53 mutation.
    Yuan L; Wang Y; Xie R; Lin D; Wang X
    Stem Cell Res; 2023 Dec; 73():103230. PubMed ID: 37890328
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Generation, characterization, and differentiation of induced pluripotent stem-like cells in the domestic cat.
    Kanegi R; Hatoya S; Kimura K; Yodoe K; Nishimura T; Sugiura K; Kawate N; Inaba T
    J Reprod Dev; 2023 Dec; 69(6):317-327. PubMed ID: 37880086
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Effect of Human Bone Marrow Mesenchymal Stem Cells with Ectopic High oct4 Expression on T Lymphocyte Function].
    Guo XP; Chen YF; Chen P; Pan J; Ying PT; Zhao N; Tang YM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1523-1530. PubMed ID: 37846711
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Multidrug resistance phenotype and its relation to stem cell characteristics in chronic myeloid leukemia.
    Lettnin AP; Wagner EF; Salgado MTSF; Cañedo AD; Rumjanek VM; Trindade GS; Votto APS
    Gene; 2024 Jan; 892():147848. PubMed ID: 37774806
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. MCL1 Inhibition Overcomes the Aggressiveness Features of Triple-Negative Breast Cancer MDA-MB-231 Cells.
    Pratelli G; Carlisi D; Di Liberto D; Notaro A; Giuliano M; D'Anneo A; Lauricella M; Emanuele S; Calvaruso G; De Blasio A
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446326
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Dysregulated YAP1/Hippo Pathway Contributes to Doxorubicin (ADM) Resistance in Acute Myeloid leukemia (AML).
    Song Y; Chen X; Huang R; Liu J
    Curr Pharm Biotechnol; 2023; 24(5):676-685. PubMed ID: 35718982
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Identification of MAEL as a promoter for the drug resistance model of iPSCs derived from T-ALL.
    Chen X; Wen F; Li Z; Li W; Zhou M; Sun X; Zhao P; Zou C; Liu T
    Cancer Med; 2022 Sep; 11(18):3479-3490. PubMed ID: 35488386
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Hsa-miR-625 Upregulation Promotes Apoptosis in Acute Myeloid leukemia Cell Line by Targeting Integrin-linked Kinase Pathway.
    Aliabedi B; Mousavi SH; Ebrahimi M; Alizadeh S; Hedayati Asl AA; Mohammad M; Samieyan Dehkordi S
    Asian Pac J Cancer Prev; 2022 Apr; 23(4):1159-1167. PubMed ID: 35485671
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. 5-
    Suksamai D; Racha S; Sriratanasak N; Chaotham C; Aphicho K; Lin ACK; Chansriniyom C; Suwanborirux K; Chamni S; Chanvorachote P
    Mar Drugs; 2022 Mar; 20(4):. PubMed ID: 35447911
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Effects of Monoammonium Glycyrrhizinate on Stem Cell-like Characteristics, Oxidative Stress and Mitochondrial Function of Acute Promyelocytic leukemia NB4 Cells].
    Chen Y; Wen XX; Zhou CY; Zhang R; Wu BJ; Yu W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):22-29. PubMed ID: 35123599
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic significance of NT5E/CD73 in neuroblastoma and its function in CSC stemness maintenance.
    Jain D; Somasundaram DB; Aravindan S; Yu Z; Baker A; Esmaeili A; Aravindan N
    Cell Biol Toxicol; 2023 Jun; 39(3):967-989. PubMed ID: 34773529
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The Pro-Survival oct4/Stat1/Mcl-1 Axis Is Associated with Poor Prognosis in Lung Adenocarcinoma Patients.
    Su YC; Chen YC; Tseng YL; Shieh GS; Wu P; Shiau AL; Wu CL
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685622
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. CD44 loss of function sensitizes AML cells to the BCL-2 inhibitor venetoclax by decreasing CXCL12-driven survival cues.
    Yu X; Munoz-Sagredo L; Streule K; Muschong P; Bayer E; Walter RJ; Gutjahr JC; Greil R; Concha ML; Müller-Tidow C; Hartmann TN; Orian-Rousseau V
    Blood; 2021 Sep; 138(12):1067-1080. PubMed ID: 34115113
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Disturbed progesterone signalling in an advanced preclinical model of endometriosis.
    Esfandiari F; Heidari Khoei H; Saber M; Favaedi R; Piryaei A; Moini A; Shahhoseini M; Ramezanali F; Ghaffari F; Baharvand H
    Reprod Biomed Online; 2021 Jul; 43(1):139-147. PubMed ID: 34049811
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. PHF20 inhibition promotes apoptosis and cisplatin chemosensitivity via the oct4‑p‑STAT3‑MCL1 signaling pathway in hypopharyngeal squamous cell carcinoma.
    Liu X; Zhang Z; Kan S; Lv Z; Zhou S; Liu X; Jing P; Xu W
    Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 33982773
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Long non-coding RNA LINC00649 regulates YES-associated protein 1 (YAP1)/Hippo pathway to accelerate gastric cancer (GC) progression via sequestering miR-16-5p.
    Wang H; Di X; Bi Y; Sun S; Wang T
    Bioengineered; 2021 Dec; 12(1):1791-1802. PubMed ID: 33975517
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Ampelopsin Inhibits Cell Proliferation and Induces Apoptosis in HL60 and K562 leukemia Cells by Downregulating AKT and NF-κB Signaling Pathways.
    Han JM; Kim HL; Jung HJ
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924032
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 11.